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Abstract
Trypanosoma vivax is one of the most common parasites responsible for animal trypanosomosis, and although this disease
is widespread in Africa and Latin America, very few studies have been conducted on the parasite’s biology. This is in part
due to the fact that no reproducible experimental methods had been developed to maintain the different evolutive forms
of this trypanosome under laboratory conditions. Appropriate protocols were developed in the 1990s for the axenic
maintenance of three major animal Trypanosoma species: T. b. brucei, T. congolense and T. vivax. These pioneer studies
rapidly led to the successful genetic manipulation of T. b. brucei and T. congolense. Advances were made in the
understanding of these parasites’ biology and virulence, and new drug targets were identified. By contrast, challenging in
vitro conditions have been developed for T. vivax in the past, and this per se has contributed to defer both its genetic
manipulation and subsequent gene function studies. Here we report on the optimization of non-infective T. vivax
epimastigote axenic cultures and on the process of parasite in vitro differentiation into metacyclic infective forms. We have
also constructed the first T. vivax specific expression vector that drives constitutive expression of the luciferase reporter
gene. This vector was then used to establish and optimize epimastigote transfection. We then developed highly
reproducible conditions that can be used to obtain and select stably transfected mutants that continue metacyclogenesis
and are infectious in immunocompetent rodents.
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Introduction
Trypanosoma vivax and Trypanosoma congolense are the main parasite
species responsible for Animal African Trypanosomosis (AAT) or
Nagana. This disease causes about 3 million deaths annually and
has a marked impact on agriculture in sub-Saharan and South
American endemic countries, leading to annual livestock produc-
tion losses of about 1.2 billion US dollars [1–3]. T. vivax accounts
for up to half of total AAT prevalence in West Africa where it is
considered a predominant pathogen for domestic animals [2,3].
The main symptoms in cattle correspond to weight loss, high
abortion rates, decreased milk production, and reduced draught
power and endurance [2,3]. T. vivax presents a short and simple
life cycle in contrast to T. brucei [4] and to a lesser extend to T.
congolense. In tsetse flies, T. vivax development takes place in the
proboscis where bloodstream forms (BSF) evolve to epimastigotes,
a non infective, replicative form. After a multiplication phase,
these epimastigotes undergo metacyclogenesis and transform into
metacyclic infective forms, and here it is noteworthy that Glossina
spp. are the only vectors in which T. vivax is able to multiply and
pursue its differentiation into metacyclic forms. West African T.
vivax populations have been introduced into South American
countries - devoid of the tsetse fly - where they are now a real
threat since they can be efficiently transmitted across vertebrate
hosts by other hematophagous insects, including tabanids. In this
case the parasites are transmitted mechanically between vertebrate
hosts in a noncyclical manner, i.e. with no growth or multiplica-
tion in the insects [5,6]. This simpler lifecycle enables T. vivax to
adapt to different vectors and hosts and may explain why it has
emerged so rapidly in South America.
Despite the fact that T. vivax has a major impact on emerging
economies, limited efforts have gone into its study during the last
decade. For our part, we have recently developed in vivo laboratory
models of T. vivax infection, we initiated a detailed assessement of its
infectious processes and characterized some of the key players in the
immunopathology of experimental trypanosomosis [7,8]. Our work
showed that sustained and reproducible infections can easily be
obtained using C57BL/6, BALB/c and Outbred mice that reproduce
the parasitological, histological and pathological parameters of the
livestock infection found in the field. These experimental in vivomodels
are useful in work conducted to explore the immunobiology of T. vivax
infection and are essential in efforts made to elucidate, for instance, the
function of some virulence factors in vivo [9,10].
Over the last decade, recombinant gene technology has
expanded our ability to investigate gene expression and function
in trypanosomatids. However, transgenesis and the selection of
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recombinant mutants depend on our ability to maintain and grow
trypanosomes in axenic cultures. The growth of insect forms of T.
vivax in vitro was firstly described by Trager in 1959 and in the mid
1970s, in the presence of tsetse tissues [10], but the cultures were not
stable and parasites did not survive for more than 18 days. Later,
Isoun and Isoun took T. vivax BSF from infected cattle and
managed to transform these into epimastigote forms without using
insect or mammalian tissues. Unfortunately, dividing parasites
were unable to withstand subculturing [11]. New methods initially
dependent on feeder layer cells and subsequently adapted for the
axenic cultivation of epimastigote and metacyclic forms of T. vivax
were later proposed by several groups in the eighties and the
nineties [12–18]. But presently, a general consensus among T.
vivax researchers involves the difficulties to maintain the parasite in
culture using the principles described in these pioneer reports [19].
This raises some concerns about the composition of the culture
media described. Furthermore, this lack of a robust and efficient
method for maintaining the parasite in vitro may readily explain the
total absence of any genetic tools for engineering T. vivax, and this
in turn has made it difficult to analyze parasite gene expression
and function.
We describe herein the successful development and standard-
ization of in vitro axenic cultures of epimastigote forms of T. vivax
obtained from BSF of the IL 1392 parasite strain stably kept in vivo
[8]. This West African stock of T. vivax is derived from the
Nigerian isolate Zaria Y486 which is infective for rodents and can
be cyclically and/or mechanically transmitted [20,21]. Cultured
epimastigote forms continue their differentiation in vitro into
metacyclic parasites and thus acquire infectious properties in mice.
In addition, we describe the first integrative expression vector for
T. vivax, designed to constitutively express foreign gene products
and bearing the neomycin phosphotransferase (NeoR) selectable
marker which confers resistance to G418. This expression system
also harbors a long ribosomal promoter region of T. vivax to drive
transcription of the reporter and NeoR genes and thus improve
gene expression and permit recombinant selection.
We used this vector to establish conditions conducive to the
efficient and highly reproducible transfection and selection of T.
vivax epimastigote mutants. We show here that the pTvLrDNA-
Luc plasmid is appropriately integrated and that the product of the
reporter gene is expressed at detectable levels. Finally, the culture
protocols described herein were used successfully for the in vitro
selection, growth and development of all the evolutive forms of
genetically engineered T. vivax that are infectious to immunocom-
petent mice.
Materials and Methods
Ethics statement
All mice were housed in our animal care facilities in compliance
with European animal welfare regulations. Institut Pasteur is a
member of Committee #1 of the Comite´ Re´gional d’Ethique pour
l’Expe´rimentation Animale (CREEA), Ile de France. Animal housing
conditions and the protocols used in the work described herein
were approved by the ‘‘Direction des Transports et de la Protection du
Public, Sous-Direction de la Protection Sanitaire et de l’Environnement, Police
Sanitaire des Animaux’’ under number B 75-15-28, in accordance
with the Ethics Charter of animal experimentation that includes
appropriate procedures to minimize pain and animal suffering.
PM is authorized to perform experiments on vertebrate animals
(license #75–846 issued by the Paris Department of Veterinary
Services, DDSV) and is responsible for all the experiments
conducted personally or under her supervision as governed by
the laws and regulations relating to the protection of animals.
T. vivax parasite strain and in vivo maintenance
Trypanosoma (Dutonella) vivax IL 1392 was originally derived from
the Zaria Y486 Nigerian isolate [8,22]. These parasites had
recently been characterized and were maintained in the laboratory
by continuous passage in mice, as previously described [8]. Seven
to 10-week-old male Swiss Outbred (CD-1, RJOrl:SWISS) or
BALB/c mice (Janvier, France) were used in all experiments. Mice
were injected intraperitoneally with bloodstream forms of T. vivax
(103 parasites/mice) or with cells derived from axenic cultures
(26106 metacyclic-like trypomastigotes). Parasitemia was deter-
mined as previously described [9]. All animal work was conducted
in accordance with relevant national and international guidelines
(see above).
Parasite maintenance in axenic cultures and in vitro
differentiation
Epimastigote cultures were initiated with the blood of infected
mice once parasitemia reached at least 5.108 parasites/ml. Blood
was collected by cardiac puncture onto heparin (2500 IU/kg), and
was then diluted 1 : 8 (v/v) with PBS 20.5% glucose to 5.107
parasites/ml. Parasites were separated from red blood cells by
differential centrifugation using a swingout rotor (Jouan GR412,
Fisher Bioblock Scientific, Strasbourg, France). This technique
offered a higher index of recovery of viable BSF (4.0–4.56108
BSF, corresponding to 80–90% recovery) than classic ion-
exchanged chromatography using DEAE-cellulose based methods.
Briefly, diluted blood was processed by one first round of
centrifugation (5 minutes at 200 g) and the supernatant withdrawn
with a Pasteur pipette without disturbing the red blood cell layer
and the thin interface containing the white blood cells. Parasite-
enriched suspension was submitted to a second round of
centrifugation (10 minutes at 300 g). Supernatant was then
centrifuged 10 minutes at 1800 g and BSF - containing pellets
devoid of host cells used to inoculate culture flasks containing
different culture medium to a final concentration of 106 to 107
parasites per ml. These were then incubated at 27uC in an
atmosphere devoid of CO2 (see Table 1 for details). Parasite
adhesion was checked by visual inspection after 4 to 5 days when
half the media had to be changed. Cultures were maintained in
Author Summary
Trypanosoma vivax is a major parasite of domestic animals
in Africa and Americas. Most studies on this parasite have
focused on gathering epidemiological data in the field.
Studies on its biology, metabolism and interaction with
the host immune system have been hindered by a lack of
suitable tools for its maintenance in vitro and its genetic
engineering. The work presented herein focused on
determining axenic conditions for culturing and growing
insect (epimastigote) forms of T. vivax and prompting their
differentiation into metacyclic forms that are infectious for
the mammalian host. In addition, we describe the
development of appropriate vectors for parasite transgen-
esis and selection in vitro and their use in analyzing
genetically modified parasite lines. Finally, we report on
the construction of the first T. vivax recombinant strain
that stably expresses a foreign gene that maintains its
infectivity in immunocompetent mice. Our work is a
significant breakthrough in the field as it should lead, in
the future, to the identification of parasite genes that are
relevant to its biology and fate, and to work that may shed
light on the intricacies of T. vivax–host interactions.
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25 cm2 polystyrene flasks (T25) (Corning, Bagneaux-sur-Loin) by
changing 3 ml of medium every 2 or 3 days. The TV1–5 media
used in this study were based on D-MEM (Dulbecco’s Modified
Eagle’s Medium, Invitrogen) or IMDM (Iscove’s Modified
Dulbecco’s Medium, Invitrogen). These media were supplemented
with 0–0.4% glucose, 0–20% heat-inactivated fetal calf serum
(FBS, MP Biomedicals or Invitrogen) and/or 0–20% heat-
inactivated goat serum (GS, Invitrogen), 0.03 mM bathocuproi-
nedisulfonic acid, 0.45 mM L-cysteine, 0.2 mM hypoxanthine,
0.14 mM ß-mercaptoethanol, 0.4–6 mM L-proline, 0.05 mM
thymidine, and 25 mM HEPES pH7.4, as indicated in Table 1.
All supplements were obtained from Sigma Aldrich except HEPES
(Invitrogen, Cergy Pontoise).
Conditioned medium consisted of 1 volume of centrifuged
(10 minutes at 1800 g) and filtered supernatant from 2- to 3-week-
old cultures, diluted with 2 volumes of fresh medium.
Fluorescence microscopy
Parasites from the supernatant or from the adherent layer were
collected, washed in PBS and resuspended at 5.107/mL. 40 mL of
the various suspensions were spotted onto coverlips and allowed to
settle for 10 min before being fixed for 15 s in cold methanol.
Slides were incubated for 1 h at 37uC with mouse monoclonal
antibodies directed against paraflagellar rod protein 2 (anti-PFR2
L8C4) [23]. They were then washed 5 times with PBS and
incubated for 45 min with a goat anti-mouse IgG secondary
antibody labeled with Alexa Fluor 488 (MolecularProbes, France).
DNA was stained with 3 mg/mL 49,69-diaminido-2-phenylindole
(DAPI, Sigma-Aldrich) for 10 min at room temperature and the
slides were washed 5 times and finally mounted in Fluoromount G
(Interchim, Montluc¸on). Parasite forms were examined under an
Olympus immunofluorescence multifilters BH-2 UV (Zeiss) or
DMR (Leica) microscope. Images were captured, for instance
using a CoolSnap HQ camera (Roper Scientifique).
Construction of the pTvLrDNA-luc vector
Several steps were required to construct the first T. vivax
specific vector (see Table 2 for primer sequences). Initially,
TvPRAC 59UTR sequence containing the Spliced leader
Acceptor Site (p.-582 to p.-1) was amplified from BSF T. vivax
genomic DNA using SLasF 59 and SLasRmcs multiple cloning
site primers. The amplified product (617 bp) was subcloned into
pCR Blunt topo vector (Invitrogen); this construct was submitted
to nested PCR using SLasKpnI-F and McsSacI-R primers to
introduce specific KpnI and SacI sites. A 616 bp fragment was
then obtained after KpnI and SacI digestions and appropriately
inserted into pBlueScript KS to create pTv59UTRa. The T. vivax
intergenic region between a and b tubulin (Tvtubab) was
amplified from BSF genomic DNA using TvTubabBam-F and
TvTubabAsc-R primers. The fragment obtained (506 bp) was
digested with BamHI and AscI and inserted into BamHI and AscI
sites of the pTv59UTRa vector. The neomycin resistance gene
cassette (NeoR) was excised from pXS2-GFP [24], by digestion
with AscI/PacI and the 802 bp Neo-fragment further inserted
downstream of TvTubab to produce vector pTv59UTRb. In
order to provide a putative 39 polyadenylation signal for the NeoR
gene, the 330 bp intergenic region located between TvTub b and
TvTub a was amplified by PCR using TvTubbaF and
TvTubbaSac-R and the resulting fragment was digested with
PacI/SacI and subcloned into the PacI/SacI sites of the
pTv59UTRb digested vector. Firefly luciferase reporter gene
was purified from Trypanosoma brucei pLEW100 vector [25],
digested with HindIII and BamHI and cloned among the TvPRAC
59UTR and TvTubab sequences of pTv59UTRb to produce pTv-
LUC. Finally, 2 derivatives of pTv-LUC were constructed
containing a long (1.8 kb, LrDNA) or a short (1.2 kb, SrDNA)
upstream of the 18S rDNA sequence. These putative RNA PolI
promotor regions were amplified with TvrDNAK-F and
TvrDNAK-R primers and further inserted into the KpnI site of
pTv-Luc to produce the final expression vectors pTvLrDNA-Luc
and pTvSrDNA-Luc. All steps in these constructions were
validated by sequencing to check that the different fragments
were in the correct location and orientation.
pTvLrDNA-GFP vector construction
The GFP cassette was excized from the vector pXS2-GFP [24]
by HindIII and EcoRI digestion. The resulting gene fragment
Table 1. Parasite culture media.
Medium HMI107 B TV1 TV2 TV3 TV4 TV5
Base IMDM IMDM IMDM or DMEM IMDM or DMEM IMDM and DMEM DMEM IMDM
FCS (%) 20 20 20 - 10 10 10
GS (%) - - - 20 10 10 10
Glucose (%) 0.4 0.4 0.4 - 0.2 0.2 0.4
L-Proline (mM) 0.6 6 2 2 1–4 2 2
doi:10.1371/journal.pntd.0001461.t001
Table 2. Primer sequences.
SLasF 59- GAGCTCGGTAGGGAGGCGATACC- 39
SLasRmcs 59- GGTACCTTAATTAAGGCGCGCCGGATCCTCTA
GAGAATTCAAGCTTCTCAACAACGCGC- 39
SLasKpnl-F 59- GCGGTACCGGTAGGGAGGCGATACC- 39
McsSacI-R 59- GCGAGCTCTTAATTAAGGCGCGCCGGATCC- 39
TvtubabBam-F 59- GCCGGATCCACGCCCCGTTGTTGCGGGCC- 39
TvtubabAsc-R 59- CGGGCGCGCCATTCGCTTGGGTTTTCTTGG- 39
Tvtubba-F 59- CGTTAATTAAACGACGCCCACTTCCCCACC- 39
TvtubbaSac-R 59- CGGAGCTCGACGGACCGAAGGAGTTCG- 39
TvrDNAK-F 59- GCGGTACCGAGGAGCTGATTTCGCCACTGC- 39
TvrDNAK-R 59- GCGGTACCGCTTCACTTGATGATCGTTTCG- 39
upFrProm 59- CGCGTGCTTGCCGAGCGCCGCGTGT- 39
upRrProm 59- GTCTCTGTTCAAAATTAATGGTATCGCCTC- 39
downFrProm 59- CGGCCAGTGAATTGTAATACGACTC- 39
downRrProm 59- GCGAGTGAGGGGGCGGCAGGCGCA- 39
doi:10.1371/journal.pntd.0001461.t002
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(714 bp) was used to replace the firefly luciferase reporter gene of
the pTvLrDNA-Luc vector between the TvPRAC 59UTR sequence
(HindIII site) and the intergenic region Tvtubab (EcoRI site). As here
above, appropriate replacement was validated by sequencing.
Trypanosome transfection
Parasites were recovered from the flasks after 15 to 20 days of
culture. In order to recover adherent parasites without causing
physical damage, the flasks were washed twice with PBS 20.5%
glucose and adherent cells were detached from the surface of the
plastic using a cell scraper in the presence of PBS.
For transfection using the Gene Pulser system (Biorad, Marnes-
la-Coquette), parasites were washed and resuspended in Cytomix
at 0.5–1.56108 cells/ml then 500 ml suspensions were mixed with
5–20 mg vector DNA and electroporated in a 4 mm gap cuvette
using two consecutive pulses of 1.2–1.8 kV, 200 V resistance and
50 mF capacitance. For the Amaxa nucleofections, pellets
containing 0.5–1.56108 parasites were resuspended in 100 ml of
Human T Cell solution (Lonza, Levallois Perret), mixed with
20 mg of circular or linearized plasmids and subjected to
nucleofection using the 5 different Amaxa programs. The total
volume of transfections was adjusted to 3 ml with TV3 medium
and incubated at 27uC. Forty eight hours after transfections, G418
(Invitrogen, Life Technologies, Villebon sur Yvette) was added to
the cultures at a final concentration of 0.5 mg/ml to allow selection
of recombinant T. vivax. Genetically engineered parasites, whose
resistance to G418 was confered by the Neo gene, were selected
over time when a massive cell death was observed in the cultures
leaving colonies of stably transformed T. vivax behind (generally
after 10 days). Total parasite genomic DNA was prepared from in
vitro cultures with pure link genomic DNA (Invitrogen, Life
Technologies, Villebon sur Yvette). Correct plasmid integrations
were checked by PCR using standard techniques and upFrProm/
upRrProm or downFrProm/downRrProm oligonucleotides pairs
and Dream Taq polymerase (Fermentas, Villebon sur Yvette,
France).
In vitro luciferase assay
A luciferase assay kit (Roche Molecular Biochemicals; Man-
nhein, Germany) was used to monitor luciferase expression. Serial
dilutions of parasite suspensions were washed in PBS and pellets
were resuspended in 150 ml of cell lysis buffer. Debris was removed
by centrifugation. The lysates were then transferred into white, 96-
well microplates (Dynex Technologies, Chantilly, France). Light
emission was initiated by adding the luciferin-containing reagent,
in accordance with manufacturer instructions. The plates were
immediately transferred to the luminometer (Berthold XS3 LB960)
and light emission measured for 0.1 s. Luminescence was
expressed as Relative Light Units (RLU).
Flow cytometry
Wild type or TvGFP parasites were recovered from 14 days
axenic cultures in TV3 medium. Adherent and supernatant cell
populations were washed and resuspended in PBS 20.5%
glucose balanced salt solution (26106 cells/ml) containing
1 mg/ml of propidium iodide. Two-color acquisition was carried
out with a FACScalibur cytofluorometer (Becton Dickinson).
Dead cells were excluded from the analysis by gating out
propidium iodide-stained cells. Parasites were gated on forward-
light scatter/side-light scatter combined gate, and 40000 events
were acquired. Results were analyzed by FlowJo software (Tree
Star, Inc).
Results
Establishment of T. vivax axenic cultures and impact of
serum source
We started T. vivax adaptation to axenic cultures using parasites
previously adapted in vivo in mice [8]. More specifically, we began
by inoculating HMI107 or B media with BSF purified from
infected mice and incubating the preparations at 27uC, as
described by Hirumi et al. in 1991 or by Gumm, in 1991,
respectively [14,15]. Various protocols were tested, e.g. different
BSF levels, different concentrations of the various amino acids,
different pH values, temperatures, reducing agents, and type of
flask, but none of the cultures developed. Since the absence of
glucose had previously been described as a factor triggering T.
brucei BSF differentiation into procyclic forms [26], we used
purified bloodstream forms of T. vivax to inoculate TV1 and TV2
media that varied in composition mainly in terms of serum nature
and/or the presence of glucose (see Table 1 for details). BSF
parasites were observed to be highly mobile for the first 3 days of
cultivation in both TV1 and TV2 media. By day 4, some parasites
started to attach to the surface of the plastic and showed some of
the morphological changes commonly seen in BSF that are
differentiating into epimastigote forms, as previously described by
Gumm [14]. Differentiating parasites replaced the prominent
undulating membrane by a flagellum that emerges from the
anterior portion of a shorter body and an anterior kinetoplast.
However, the parasites were still unable to divide, and this in both
TV1 and TV2 media, and they died after 7 days or 14 days,
respectively. When grown in TV3 medium - that contains an
equivalent mixture of complete IMDM and DMEM media (vol/
vol) - BSF attached to the plastic flask after 4–5 days, suggesting
that they were engaged in the process of differentiation into
epimastigote cells. Three days later (day 7/8 of culture), some
parasites were seen to have shortened, indicating that they had
differentiated into epimastigotes. Even more importantly, they
started to multiply by forming small clusters (Figure 1 A–C). These
clusters increased in number and size and 3 to 4 weeks later had
covered the entire surface of the culture flask. At this stage, both
rosettes and free-swimming cells (1.5.107 cells/flask) became
abundant in the supernatant and these parasites could then be
used to inoculate new flasks.
In order to determine whether the mixture of the two sera and/
or medium composition was critical for growth, parasites obtained
from the TV3 culture supernatant were used to inoculate fresh
flasks containing IMDM or DMEM supplemented with 10% FCS,
10% GS and different concentrations of glucose (TV4 and TV5
media, respectively), comparable to those in TV1 and TV2 media.
Only IMDM-based medium (TV5) supported T. vivax growth at
similar kinetics to TV3 medium, and this regardless of the glucose
concentration. Different combinations (vol/vol) of five batches of
Figure 1. Establishment of axenic cultures of T. vivax epimas-
tigotes. BSF (A), BSF-derived epimastigotes (B), Epimastigotes forming
rosettes in the culture supernatants (C).
doi:10.1371/journal.pntd.0001461.g001
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fetal calf sera and three batches of goat sera were able to support
growth without any significant differences (data not shown),
indicating that the positive effect of goat serum on T. vivax growth
is not an artifact due to serum batch heterogeneity. Conversely,
parasites were unable to grow in media supplemented solely with
20% FCS or 20% GS. Medium TV3 was therefore chosen for all
subsequent cultures and experiments.
Characterization of culture stages and epimastigote in
vitro differentiation
Parasite growth kinetics and metacyclogenesis were investigated
to characterize the parasite stages observed during axenic culture.
As can be seen in Figure 2, TV3 medium was inoculated with
1.5.107 cultured parasites and their development was monitored
for three weeks. The parasites attached to the surface of the plastic
within 2 hours (Figure 2A) and formed micro-colonies after 7 days
(Figure 2B). Conspicuous parasite multiplication was then
observed for the following week and cells completely covered the
entire surface of the plastic between days 14 and 21 (Figure 2C
and 2D). Parasite cell numbers were determined in the
supernatant and the number of adherent cells was evaluated after
scraping. As shown in Figure 2E, the number of cells in the
supernatant increased with time and in proportion to the density
of the adherent cell layer. A confluent 25 cm2 flask was able to
produce 5.107 to 1.108 parasites in the supernatant every two days.
With appropriate care and a medium amendment (see below), it
was possible to conserve parasite viability in a single flask for 6 to
10 weeks. In addition, the supernatants provided a sufficient
number of parasites to initiate new cultures and thus support
regular in vitro passages weekly or every 2–3 weeks.
In efforts to determine whether established culture conditions
were suitable for the differentiation of epimastigotes into infective
metacyclics, we monitored the proportions of the different parasite
forms in ongoing cultures. The relative positions of nuclei and
kinetoplasts were evaluated by immunofluorescence after DNA
staining with DAPI, and flagellum length and position were
determined using antibodies to label paraflagellar rod protein 2
(PFR2) [23]. As shown in Figure 3A, the kinetoplast in epimastigote
forms was located between the nucleus and the anterior part of the
cell body, whereas metacyclic-like trypomastigotes had a longer
body-attached flagellum and a kinetoplast posterior to the nucleus.
Numerous epimastigotes in the cultures were also observed to be
dividing. Changes in parasite forms present in the supernatant and
in the adherent layer were monitored throughout the culture period
and the populations in each developmental stage were quantified on
culture days 7, 14 and 21. We observed that the different
populations that made up the adherent layer did not change in
proportion over time, with the vast majority (about 74%) of cells
consisting of epimastigotes throughout the plastic colonization
period (Figure 3B). The total proportion of epimastigotes was stable
throughout the culture and only 24 to 32% were actively dividing
cells. Some metacyclic-like cells were also observed in the
population of attached cells, but accounted for only a small and
invariant proportion (about 5%). Conversely, changes in the
trypomastigote population in the supernatant suggested that an
active process of epimastigote differentiation into metacyclic cells
(metacyclogenesis) was taking place. For instance, the parasite
population in the supernatant after 7 days was similar to that
observed in the adherent layer. A substantial change then occurred
from day 14 with a dramatic increase in the proportion of
metacyclic-like parasites (3 to 19%). This was accompanied by a
considerable decrease in the number of epimastigotes and abnormal
cells in the supernatant. The population of metacyclic-like cells
peaked at this point then decreased by day 21.
The virulence of these axenic trypomastigotes was assessed by
first collecting parasite populations from ongoing culture super-
natants and analyzing these by immunofluorescence. The results
showed that 2%, 19% and 16% of metacyclic-like cells were
present on days 7, 14 and 21, respectively. Equivalent numbers of
metacyclic-like cells (26106) were then injected intraperitoneally in
3 groups of 5 Balb/c mice and parasitemia was measured over a
period of 28 days (Figure 3C). The results showed that 40%, 80%
and 20% of individual blood smears contained BSF parasites
(.104 parasites/ml) between days 12 and 21. Since equivalent
numbers of metacyclic-like cells were injected into the mice, our
results indicated that the metacyclic-like cells present in the
cultures were at different stages in their maturation and that the
axenic differentiation process is not synchronous.
Figure 2. Kinetics of T. vivax growth in vitro. Microscopic examination of adherent cells 2 hours (A), 7 days (B), 14 days (C) and 21 days (D) after
inoculation with 1.5.107 parasites. 1006magnification. Parasite numbers in ongoing cultures (E). Results are expressed as arithmetic means 6 SD.
doi:10.1371/journal.pntd.0001461.g002
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Factors affecting T. vivax epimastigote adhesion and
growth in axenic cultures
Marked alkalinization of the TV3 medium was observed less
than 30 minutes after the epimastigotes became attached to the
plastic surface (the pH increased from 7.4 to 8.6). When the
parasites were left at this high pH, they adopted a round shape and
died. This phenomenon was prevented by increasing the HEPES
final concentration to 100 mM and in this manner the pH was
held at 7.4 during the initial growth process. We observed that
adherent parasites could not be easily removed from the plastic
surface and attempts to use a cell scraper were unfruitful, causing
death in most of the parasites. Since the pH appears to be critical
for adhesion, we analyzed whether pH variations impacted on
parasite attachment. Confluent flasks were washed twice with PBS
at pH 7.4, pH 6 or pH 8.5. Each of the three washing conditions
led to partial cell detachment (around 108 cells) but the adherent
cells that remained (approximately 26108) could then be easily
scraped off the plastic surface without cell damage. The removal of
medium (and probably serum), rendered the attached cells less
cohesive and loosened cells that presented higher levels of viability.
Such a procedure was employed to provide 3.108 cells in a T25
confluent flask, and these were used to reinoculate fresh flasks or to
carry out further experiments.
Since L-proline is well known to be an important source of
carbon for trypanosomes [27], T. vivax epimastigote growth was
also estimated at different proline concentrations (1 mM, 2 mM,
4 mM) in TV3 medium. 107 cells were used to inoculate T25
flasks and the time required to obtain a confluent layer of cells was
determined. As the proline concentration in the flask increased,
the time required to obtain confluence decreased, from 3–4 weeks
(1 mM proline) to 14 days (4 mM proline). Since variations in
glucose concentrations did not affect parasite growth, the results
here indicate that proline is a key player in the growth of T. vivax
epimastigotes. Our data showed that 4 mM L-proline was the
optimal concentration in TV3 medium. Higher concentrations did
not significantly improve culture conditions or parasite growth and
maintenance.
The effects of epimastigote density on cultivation were studied
by performing a limiting dilution assay using fresh or conditioned
media [28–30]. Here, 107 to 104 parasites were used to inoculate
flasks containing TV3 media. The density of adherent cells and the
presence of micro-colonies on the plastic surface were scored after
3 weeks of culturing at 27uC, with regular changes of the media.
Epimastigotes used to inoculate fresh TV3 media, at concentra-
tions of less than 106/per T25 flask became round, were unable to
multiply and died after a week. By contrast, when using
conditioned media containing 30% supernatant from former T.
vivax cultures, flasks inoculated with only 105 parasites gave rise to
dense parasite clusters after 4 weeks. Micro-colonies 2 mm in
diameter were also observed after 4 weeks in flasks inoculated with
104 cells, and these reached confluence by 6 weeks.
Genetic tool design and transfection of T. vivax
epimastigotes
No genetic manipulation of T. vivax has ever been described in
the literature, nor any expression of transgenes. We therefore
began by constructing plasmids containing the luciferase reporter
gene (see Material and Methods) in efforts to determine
appropriate conditions for reproducible transfection of T. vivax.
Figure 4A schematically represents pTv-Luc vector that was
specially designed in order for T. vivax to express the luciferase
gene and neomycin phosphotransferase (NeoR), which confers
resistance to G418. Upstream of the reporter gene we cloned the
59UTR of the T. vivax proline racemase gene (PRAC) that contains
Figure 3. Characterization of T. vivax developmental stages in vitro. Supernatant and adherent layer parasites taken from ongoing axenic
cultures were labeled with anti-PFR2 antibodies (see Methods), stained with DAPI and examined under an epifluorescence microscope: n = nucleus;
k = kinetoplast; fl = flagellum (A). Bars represent relative numbers in each parasite population (B). Metacyclic-like parasites in culture supernatants
were quantified by IMF on days 7, 14 and 21. An equivalent number of metacyclic-like trypomastigotes (26106) were taken at each time point and
injected intraperitoneally in groups of 5 Balb/c male mice. Parasitemia was measured individually for 28 days and the number of positive mice (and %
within the group) was noted.
doi:10.1371/journal.pntd.0001461.g003
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an efficient spliced donor acceptor site [9]. Work in T. congolense
and T. brucei has previously identified RNA pol I promoter
elements in regions spanning 2 kb upstream of the 18 S element of
the rDNA gene cluster [31,32]. But, taking T. cruzi specific vectors
as an example [33], where poor gene expression is observed in the
absence of such sequences, we aimed to provide the T. vivax vector
with a hyperexpression cassette to regulate gene transcription. In
order to better define the region with a putative T. vivax promoter,
we constructed two different plasmids harboring respectively a
long 1.8 kb fragment (pTvLrDNA-luc) and a short 1.2 kb fragment
(pTvSrDNA-luc) upstream the 18 S rDNA gene (see Figure 4B).
Axenic T. vivax epimastigotes were then transiently transfected
with the pTv-LUC, pTvLrDNA-luc or pTvSrDNA-luc plasmids
using a Gene Pulser electroporator under high voltage conditions.
Luciferase activity was measured in the different cell lines 48 h
after transfection to check for the presence of the putative pol I
promoter in selected sequences.
Interestingly, luciferase activity was 10 times higher after
transfection with all plasmids containing the putative rDNA
promoter sequence compared to transfection with the pTvLUC
plasmid. Comparable levels of luciferase activity were obtained
with the pTvLrDNA-luc and pTvSrDNA-luc plasmids, suggesting
that the rDNA promoter region in T. vivax is located in a 1.2 kb
region directly upstream of the 18 S ribosomal DNA gene
(Figure 4B). However, given that the pTvLrDNA-luc plasmid has
a better potential for recombination, subsequent work conducted
to optimize T. vivax transfection conditions was conducted using
this vector. Different concentrations of circular plasmid molecules
were tested, and 20 mg was observed to be the optimal DNA
concentration for T. vivax transfection studies, as based on the
RLU obtained and as illustrated in Figure 5A. Different numbers
of axenic parasites were then electroporated with 20 mg of circular
plasmid. The results obtained showed that 1.5.108 parasite cells/
per transfection gave the highest RLU in the supernatant
(Figure 5B). Then, in order to check that an acceptable success
rate was obtained with T. vivax transfection, the relative efficiency
of the gene transfer was measured by comparing transfection using
a Gene Pulser system and Amaxa nucleofection. With 20 mg of
circular plasmid used in each of the transfer conditions, the
epimastigotes were subjected to 4 different Gene Pulser system
voltage conditions and to 5 different nucleofection Amaxa
programs.
Examination of the cells after Gene Pulser electroporation
showed massive rates of mortality at all voltages used (not shown).
Moreover, the parasites were unable to adhere to the plastic flasks,
and this precluded any growth in TV3 medium. By contrast, as
described previously for T. brucei and T. congolense [34,35], the
Amaxa nucleofection method greatly enhanced transfection
efficiency and additionally, T. vivax showed better adhesion to
the plastic surface and increased survival rates. Thus, as can be
seen by the expression of luciferase monitored 24 h after gene
transfer, the transfection efficiency obtained with Amaxa program
‘‘6006’’ was 25 fold higher than that obtained with the best Gene
Figure 4. Trypanosoma vivax-specific luciferase vectors. Sche-
matic representation of pTvLUC vector constructs (A); TvPRAC59UTR,
upstream of the TvPRAC region and containing spliced leader acceptor
site; Tubab, intergenic region between alpha and beta tubulin genes;
NeoR, neomycin phosphotransferase gene; Tubba, intergenic region
between b and a tubulin genes. Representation of the ribosomal
promoter region cloned into pTv-Luc and associated luminescence in
Relative Light Units (RLU) detected in the supernatant 48 h after
epimastigote transfection with pTvSrDNA-Luc and pTvLrDNA-Luc (B).
doi:10.1371/journal.pntd.0001461.g004
Figure 5. Set-up of T. vivax transfection. (A) Different doses of
circular pTvLrDNA-Luc were used to transfect 1.108 parasites using a
Gene Pulser protocol (261.6 kV) and the quantity of light emitted by
the supernatant was quantified 24 h post-transfection. Results are
expressed as arithmetic means 6 SD. (B) Using the same protocol,
transient transfection efficiency was evaluated with different parasite
loads; (C) Effect of Amaxa or Biorad Gene Pulser protocols on
electroporation efficiency. Parasites taken from supernatants are
checked for light emission 24 h post-transfection.
doi:10.1371/journal.pntd.0001461.g005
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Pulser conditions (two 1.6 kV pulses) (Figure 5C). This program
was therefore used in all subsequent experiments.
Gene integration and impact of transfection in vitro and
in vivo
Efficient selection conditions were then determined conducive
to obtaining stably pTvLrDNA-luc transfected parasites. 107
parasites were used to inoculate fresh flasks containing various
concentrations of G418 (10 to 0.25 mg/ml), and TV3 medium was
changed every 2 or 3 days. A G418 concentration of 0.5 mg/ml
was sufficient to kill all the cells after 10 days of culture. In order to
maintain the requirement for ‘quorum sensing’ on transfectant
growth, cells were maintained in TV3 conditioned media in the
presence of G418 for at least 4 weeks. In order to obtain stably
transfected parasites, we targeted the T. vivax ribosomal region by
using AfeI linearized pTvLrDNA-luc (see Figure 4B) to transfect
parasite cells and compared the results with transfections using the
circular plasmid. Following nucleofection, the cells were used to
inoculate 2 independent flasks. After 24 h, one of the flasks was
assayed for luciferase activity. Cells transfected with linear DNA
showed half the luciferase activity of those transfected with circular
DNA (Figure 6A). But after several weeks of selection with G418,
the cells transfected with circular DNA started to decay and
eventually died whereas those cells transfected with linear DNA
formed small clusters and 5 to 10 micro-colonies per flask after 4
weeks of selection. Transfection efficiency using linear DNA was
then estimated as 1.5–3.061027. The parasites reached conflu-
ence 4 weeks later and the supernatants could be transferred into
fresh flasks for selection in the presence of G418.
After selection, parasite genomic DNA was prepared from two
independent cultures stably transfected with pTvLrDNA-luc and
submitted to PCR using two primer pairs to ascertain whether
homologous recombination had occurred, as indicated in the
illustration in Figure 6B. Consistently with integration of the
pTvLrDNA-luc plasmid into the 18 S rDNA region, fragments of
the expected size (1.8 kb) were obtained after amplification for
both culture DNA (Figure 6C, upper and lower pannels),
indicating that homologous recombination had occurred upstream
the TvPRAC 59 UTR (Figure 6C, upper pannel) and downstream
the Tvtubab (Figure 6C, lower pannel) regions. The parasites were
maintained in axenic TV3 medium for several weeks and
luciferase light emission per parasite was shown to be stable over
time for at least 24 weeks (Figure 6D) and correlated linearly with
the number of parasites on a wide range (.than 4 logs, Figure 6E).
Since wild type (WT) metacyclic-like parasites produced in axenic
cultures can successfully infect mice, we examined whether this
was also the case for the stable metacyclic-like forms developed in
vitro from the TvLrDNA-luc parasite line. Initially, the equivalent
to 26106 TvLrDNA-luc metacyclic-like forms obtained from 14-
day cultures (see Figure 3C) were used to infect BALB/c mice. At
onset of BALB/c parasitemia, a corresponding number of BSF
(102) from TvLrDNA-luc or WT-infected mice were injected into
groups of 4–6 Outbred mice and the parasitemias obtained were
compared every 5 days, as previously described [8]. Figure 7
Figure 6. Obtaining the stably transfected T. vivax TvLrDNA-Luc strain. (A). T. vivax axenic epimastigotes were transfected with circular or AfeI
linearized pTvLrDNA-Luc using the 6006 Amaxa program and luciferase light emission (RLU) was measured 24 h post-transfection in the
supernatants. (B) Schematic representation of pTvLrDNA-Luc linearized with AfeI and its expected recombination in the parasite ribosomal DNA
region. Hatched boxes show ribosomal promoter-containing regions; Black crosses represent recombination events; grey arrows indicate primers
used to verify plasmid integration into T. vivax genome. 18 S, 5.8 S and 28 S, rRNA genes. (C) Verification of the 59- and 39- integration of the vector.
PCR using respectively upF/upR (upper panel) and downF/downR (lower panel) primers. PCR was performed on genomic DNA from 2 independent
cultures stably transfected with pTvLrDNA-Luc (1, 2) or from WT strain (3). (D) Changes in luminescence (RLU) emitted per pTvLrDNA-Luc parasite after
G418 selection. (E) Graphic representation of bioluminescence expressed as luciferase light emission (RLU) of increasing numbers of TvLrDNA-luc
parasites.
doi:10.1371/journal.pntd.0001461.g006
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presents the number of BSF recorded during the infection, as well
as relative survival in the two groups of mice. It can be seen that
parasitemias and survival rates were similar and not significantly
different in the mice infected with TvLrDNA-luc and those infected
with WT parasites. Therefore, after only one passage in mice, the
parasitemia kinetics obtained with cultured parasites were similar
to those observed with BSF maintained exclusively by serial weekly
passages in mice. Similar results were obtained after 2 months and
after 12 months of axenic growth, indicating that both WT and
mutant T. vivax maintained their infectivity after subculturing in
vitro.
Ongoing experiments have been performed to further validate
the transfection procedures described here above by introducing
into the T. vivax specific vector another reporter gene. For this aim,
pTvLrDNA-GFP was constructed by replacing the luciferase gene
among the TvPRAC 59UTR and TvTubab vector sequences by a
Green Fluorescent Protein (GFP) cassette excized from the pXS2-
GFP ([24], see Methods and Figure 8A). T. vivax epimastigotes
were transfected with pTvLrDNA-GFP using the Amaxa program
‘‘6006’’ and further cultured in TV3 medium at 27uC. Forty eight
hours after transfection, G418 (0.5 mg/ml) was added to the
cultures to select stable transfectants. Similarly to the parasites
transfected with pTvLrDNA-luc, massive mortality was observed up
to 10 days with the simultaneous growth of stably (neor)
transformed T. vivax that reached confluence four weeks later.
The integration of the contruction was validated by PCR using
upFrProm/upRrProm and downFrProm/downRrProm couple of
primers, as decribed for the luciferase vector (not shown). Figure 8B
shows the microscopic observation of recombinant GFP -
expressing parasites (TvGFP) obtained from 14 days axenic
subcultures. Adherent and supernatant cell populations from two
independent cultures were washed in PBS 20.5% glucose and
analyzed by cytofluorometry. The FACS analysis shows that both
adherent and supernatant TvGFP populations express highly
homogenously the GFP (app. 95%), as compared to the absence of
fluorescence of WT parasites (Figure 8C). Additional experiments
are in progress to evaluate the behavior of TvGFP in vivo.
Discussion
While human African trypanosomosis has drawn the attention
of many research groups over the last few decades, less
consideration has been given to AAT despite its considerable
impact on livestock development and fertility and the economic
hardship it causes in several countries. Major breakthroughs have
recently been made in the study of T. congolense, namely the
development and standardization of axenic cultures and the
development of transfection techniques [35,36]. Researchers had
showed growing interest in T. vivax adaptation to experimental
animals from more than twenty years after the encouraging studies
of Leeflang in the 1970s, and the description being made of
parasite isolates that were infective to rodents [22,37,38]. Much
attention had also been paid for several years to the development
of short-term axenic cultures [14–16,39]. However, few studies
conducted over the next two decades quoted these reports on T.
vivax in vitro growth or parasites obtained in culture, possibly due to
methodology inconsistencies and/or difficulties reproducing the
complexity of parasite interactions with its host environment [19].
But T. vivax still remains a threat for livestock in Africa and South
America where the disease is considered as emergent and is
consequently the subject of numerous outbreak reports [3,40].
To gain better insights into the biology of T. vivax and its
interactions with its mammalian hosts, we recently undertook a
detailed study of a pathogenic strain of the parasite that had been
isolated in West Africa and stored frozen for several decades. We
used this IL 1392 strain to establish novel mouse models of
experimental infection and immunopathology [7,8]. Today, we
report herein on how we managed to overcome the lack of genetic
tools for analyzing T. vivax gene expression and function by
standardizing the axenic conditions for epimastigote cultivation of
the IL 1392 strain and its in vitro differentiation into infectious
forms. We also constructed specific vectors appropriate for parasite
transgenesis, developed suitable conditions for T. vivax transfection
and for further selection of transfectants. Moreover, transfection
procedures were further validated by the engineering of green
fluorescent parasites that stably express the GFP reporter gene.
Finally, we carried out an in vitro and in vivo adaptation of a
transgenic TvLrDNA-luc parasite line that constitutively expresses
the luciferase reporter gene. Our data show that the TvLrDNA-luc
mutant went through all the T. vivax developmental stages in vitro,
in the same manner as WT parasites, and that metacyclic-like
forms of the mutant are infective to immunocompetent mice.
In order to overcome the difficulties found to reproduce culture
conditions described in the past we worked to optimize axenic
protocols to develop standard conditions of T. vivax maintenance
and growth. For instance, although fetal calf (FCS) or goat (GS)
sera had previously been presented as a essential medium
components for trypanosome sustenance and growth in vitro
[14,16], our experiments showed that T. vivax was unable to grow
in culture media supplemented only with FCS or GS. Successful
parasite axenic cultures were only possible when a mixture of FCS
and goat serum (GS) was used to complement the media, and this
resulted in significant BSF attachment, in significant differentiation
into epimastigotes and in further parasite growth. Moreover, in the
presence of GS, any batch of FCS could be used without affecting
parasite differentiation and development. We nonetheless noted
that the number of parasites loaded into the cultures had an
impact on axenic epimastigote cultivation. For instance, at low
densities (,106 cells/ml), T. vivax was unable to pursue its
Figure 7. Mutant TvLrDNA-Luc strain displays the same levels
of in vivo infectivity and virulence as WT T. vivax. Four to six
Outbred mice were injected intraperitoneally with 102 WT (e) or
TvLrDNA-Luc (&) BSF T. vivax parasites and parasitemia were followed
individually every 5 days. Continous and dotted lines stand respectively
for parasitemias and cumulative survival rates, as determined by
Kaplan-Meier methodology. Parasitemias are expressed as arithmetic
means 6 SD. No significance was observed between the curves, as
ascertained by the Mantel-Cox log-rank test where p.0.5.
doi:10.1371/journal.pntd.0001461.g007
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developement and the epimastigotes died in a few days without
undergoing differentiation or further divisions. Interestingly, and
in agreement with previous observations in T. brucei [28–30], this
restriction can be overcome by ensuring that up to one third of the
conditioned medium consists of supernatants from former parasite
cultures, and in this manner fewer epimastigotes can initially be
loaded (i.e. 104 parasites/ml). This observation suggests that
conditioned medium contains signaling compounds or growth
factors that are released by T. vivax in culture and these stimulate
and support the proliferation and development of new cells or at
least assist in their maintenance under axenic conditions.
It is noteworthy that the axenic culture conditions described
herein are suitable for epimastigote differentiation and for the
continuous production of metacyclic-like forms. T. vivax from the
adherent layer differentiate into infective forms without requiring
any special medium adaptation, thus mimicking the gradual
process of metacyclogenesis in culture. Interestingly, and in
contrast to T. congolense [35], T. vivax parasites that underwent
metacyclogenesis in vitro from epimastigotes and were then
conserved by regular axenic passages for more than one year,
retained their infectiveness in immunocompetent mice. And it is of
note that the factors involved in metacyclogenesis per se are not yet
known in nature or described in the literature, for T. vivax or T.
congolense. We cannot foresee whether the optimization of the
axenic parasite cultures developed here can be automatically
extrapolated to different wild type or other cloned T. vivax strains.
But, a recent report using T. congolense showed that the time period
to achieve the adaptation in axenic culture of different parasite
strains and derivatives is strain dependant [35]. Nevertheless,
previous molecular analysis of IL 1392 has proven the common
origin of this and the South American and Asian isolates that
phylogenetically pertain to the same clade [41]. It is possible that
similarly to IL 1392, strains from the same clade can be cultured
using the protocols described herein.
The development in the 1990s of Trypanosomatid transfection
using Gene Pulser systems [42–45] was then adapted to other
species [36,46,47]. Despite a number of similar transfection
parameters shared by all Kinetoplastidae, recombination efficiencies
and susceptibility to drug selection diverged. Thus, crucial
adjustments were necessary to ensure appropriate transfection
rates, such as the use of specific parasite regulatory sequences. The
vectors we constructed to establish T. vivax transfection are based
on classical models where foreign genes are placed under the
control of species-specific 59 and 39 UTRs containing the
regulatory sequences required for appropriate gene expression.
Consequently, the ribosomal promoter-containing sequence was
localized and inserted upstream of the selected transgenes to
promote their expression and genomic recombination and thus
obtain stably modified transfectants. For purposes of validating our
T. vivax-specific overexpressing vector, we compared the arche-
typal Gene Pulser transfection system with Amaxa nucleofection
technology. Amaxa technology has been reported, with T. brucei, to
greatly increase the number of transfectants obtained [34,48]. In
line with this, an initial series of experiments showed that Amaxa
protocols had two major advantages over Gene Pulser conditions:
they improved transient transfection efficiency and increased
parasite viability and adhesion to the surface of the culture flask.
Subsequent experiments showed that transfection of the T. vivax-
derived circular vector was unable to generate stable transfectants.
This may suggest that T. vivax is not able to maintain episomal
DNA, unlike T. brucei and T. congolense that carry out particular
sequences (i.e. parp) that promote episomal mantainance [36,48].
Alternatively, T. vivax circular DNA may be integrated but less
efficiently than linear plasmids, resulting in a smaller number of
live parasites that do not survive culture conditions. By contrast,
when the linearized vector was used for the transfections, this
generated stable transfectants that showed appropriate integration
of the foreign gene into the ribosomal promoter region. This result
shows that the linearized vector facilitates integration, as already
shown for other kinetoplastids [33,49].
Figure 8. Validation of stably transformed pTvLrDNA-GFP
parasites. Schematic representation of pTvLrDNA-GFP vector construct
(A); TvLrDNA-GFP parasites from axenic culture supernatants were
examined under phase contrast (left panel) and epifluorescence (right
panel) microscopy (B). Parasite populations obtained from two
independent transfections were cultured and analyzed by flow
cytometry. Dead cells were excluded from the acquisition by gating
out propidium iodide-stained cells. Parasites were further gated on
forward-light scatter/side-light scatter combined gate and the histo-
grams represent the frequency of GFP-expressing TvLrDNA-GFP cells
(%) as compared to WT, non transformed, control parasites (gray curves)
(C).
doi:10.1371/journal.pntd.0001461.g008
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In conclusion, the T. vivax strain generated in our studies and
stably expressing a luciferase reporter gene will be very useful for
characterizing the in vivo infectious process and for validating the
effectiveness of drug candidates in medium or high-throughput
screening tests. Bioluminescent T. vivax will also certainly prove
useful in enhancing our knowledge of the different aspects of
parasite development, the acquisition of virulence and the
triggering of pathology. However, cellular trafficking and locali-
zation of a given stage specific parasite protein may be promptly
assessed by parasite engineered with fluorescent specific vector
described here, where the current GFP cassette would be replaced
by a gene of interest fused to the GFP reporter. Under the same
promoter elements, transgenic parasites should express the fusion
protein linked to GFP and easily identified. The work described
herein has therefore developed the first specific genetic tools for
the study of T. vivax biology and opens up new possibilities for the
study of experimental Nagana, particularly the expression and
regulation of critical genes implicated in the parasite’s evasion of
the host immune system. Additionaly, our work also paves the way
for the development of more sophisticated tools to reduce the
expression of parasite genes by inducible RNAi or by conventional
gene knockout based on homologous recombination.
Acknowledgments
The authors are indebted to F. Bringaud, Universite´ Bordeaux Segalen, for
critical suggestions concerning the initial phases of T. vivax-specific vector
constructions, to M. C. Blom-Potar for assistance with the early steps in T.
vivax axenic cultures and to M. Jones from Transcriptum for English
corrections.
Author Contributions
Conceived and designed the experiments: SG PM. Performed the
experiments: SD MM AC NC BR SG. Analyzed the data: SD BR SG
PM. Contributed reagents/materials/analysis tools: SD MM AC NC.
Wrote the paper: SD SG PM.
References
1. Report WHO (2010) World Health Organization Report.
2. Gardiner PR, Wilson AJ (1987) Trypanosoma (Duttonella) vivax. Parasitol Today 3:
49–52.
3. Osorio AL, Madruga CR, Desquesnes M, Soares CO, Ribeiro LR, et al. (2008)
Trypanosoma (Duttonella) vivax: its biology, epidemiology, pathogenesis, and
introduction in the New World - a review. Mem Inst Oswaldo Cruz 103: 1–13.
4. Vickerman K (1976) The diversity of the kinetoplastida flagellates. In:
Lumsden WHR, Evans DA, eds. Biology of Kinetoplastida. New York &
London: Academic Press. pp 1–34.
5. Shaw JJ, Lainson R (1972) Trypanosoma vivax in Brazil. Ann Trop Med Parasitol
66: 25–32.
6. Jones TW, Davila AM (2001) Trypanosoma vivax - out of Africa. Trends Parasitol
17: 99–101.
7. Blom-Potar MC, Chamond N, Cosson A, Jouvion G, Droin-Bergere S, et al.
(2010) Trypanosoma vivax infections: pushing ahead with mouse models for the
study of Nagana. II. Immunobiological dysfunctions. PLoS Negl Trop Dis 4:
e793.
8. Chamond N, Cosson A, Blom-Potar MC, Jouvion G, D’Archivio S, et al. (2010)
Trypanosoma vivax infections: pushing ahead with mouse models for the study of
Nagana. I. Parasitological, hematological and pathological parameters. PLoS
Negl Trop Dis 4: e792.
9. Chamond N, Cosson A, Coatnoan N, Minoprio P (2009) Proline racemases are
conserved mitogens: characterization of a Trypanosoma vivax proline racemase.
Mol Biochem Parasitol 165: 170–179.
10. Trager W (1959) Tsetse-fly tissue culture and the development of trypanosomes
to the infective stage. Ann Trop Med Parasitol 53: 473–491.
11. Isoun MJ, Isoun TT (1974) The effect of HEPES buffered media on the in vitro
cultivation of Trypanosoma vivax and Trypanosoma brucei. Tropenmed Parasitol 25:
283–287.
12. Hirumi H, Nelson RT, Hirumi K () Complete cyclic development of Trypanosoma
vivax in vitro; 1983; Pace University, New York, New York. Journal of
Protozoology 6A.
13. Fish WR, Nelson RT, Hirumi H (1987) Cell adhesion in Trypanosoma: in vitro
studies of the interaction of Trypanosoma vivax with immobilized organic dyes.
J Protozool 34: 457–464.
14. Gumm ID (1991) The axenic cultivation of insect forms of Trypanosoma
(Duttonella) vivax and development to the infective metacyclic stage. J Protozool
38: 163–171.
15. Hirumi H, Hirumi K, Moloo SK, Shaw MK (1991) In vitro cultivation of blood
stream trypomastigotes of Trypanosoma vivax without feeder cell layers. J Protozool
Res 1: 1–12.
16. Zweygarth E, Gray MA, Kaminsky R (1991) Axenic in vitro cultivation of
Trypanosoma vivax trypomastigote forms. Trop Med Parasitol 42: 45–48.
17. Rebeski DE, Winger EM, Rogovic B, Robinson MM, Crowther JR, et al. (1999)
Improved methods for the diagnosis of African trypanosomosis. Mem Inst
Oswaldo Cruz 94: 249–253.
18. Hill GC, Hirumi H (1983) African trypanosomes. In: Jensen JB, ed. In vitro
Cultivation of Protozoan Parasites. Boca Raton, FL: CRC Press, Inc. pp 193–219.
19. Da´vila AMR, Guerreiro LTA, Souza SS (2005) Marker discovery in Trypanosoma
vivax through GSS and comparative analysis.the Netherlands. In: Makkar HPS,
Viljoen GJ, eds. Applications of Gene-Based Technologies for Improving
Animal Production and Health in Developing Countries. , The Netherlands.:
IAEA. pp 773–776.
20. De Gee AL, Ige K, Leeflang P (1976) Studies on Trypanosoma vivax: transmission
of mouse infective T. vivax by tsetse flies. Int J Parasitol 6: 419–421.
21. Moloo SK, Kutuza SB, Desai J (1987) Comparative study on the infection rates
of different Glossina species for East and West African Trypanosoma vivax stocks.
Parasitology 95 (Pt 3): 537–542.
22. Leeflang P, Buys J, Blotkamp C (1976) Studies on Trypanosoma vivax: infectivity
and serial maintenance of natural bovine isolates in mice. Int J Parasitol 6:
413–417.
23. Kohl L, Sherwin T, Gull K (1999) Assembly of the paraflagellar rod and the
flagellum attachment zone complex during the Trypanosoma brucei cell cycle.
J Eukaryot Microbiol 46: 105–109.
24. Bangs JD, Brouch EM, Ransom DM, Roggy JL (1996) A soluble secretory
reporter system in Trypanosoma brucei. Studies on endoplasmic reticulum
targeting. J Biol Chem 271: 18387–18393.
25. Wirtz E, Leal S, Ochatt C, Cross GA (1999) A tightly regulated inducible
expression system for conditional gene knock-outs and dominant-negative
genetics in Trypanosoma brucei. Mol Biochem Parasitol 99: 89–101.
26. Milne KG, Prescott AR, Ferguson MA (1998) Transformation of monomorphic
Trypanosoma brucei bloodstream form trypomastigotes into procyclic forms at 37
degrees C by removing glucose from the culture medium. Mol Biochem
Parasitol 94: 99–112.
27. Bringaud F, Riviere L, Coustou V (2006) Energy metabolism of trypanosoma-
tids: adaptation to available carbon sources. Mol Biochem Parasitol 149: 1–9.
28. Reuner B, Vassella E, Yutzy B, Boshart M (1997) Cell density triggers slender to
stumpy differentiation of Trypanosoma brucei bloodstream forms in culture. Mol
Biochem Parasitol 90: 269–280.
29. Vassella E, Reuner B, Yutzy B, Boshart M (1997) Differentiation of African
trypanosomes is controlled by a density sensing mechanism which signals cell
cycle arrest via the cAMP pathway. J Cell Sci 110 (Pt 21): 2661–2671.
30. Carruthers VB, Cross GA (1992) High-efficiency clonal growth of bloodstream-
and insect-form Trypanosoma brucei on agarose plates. Proc Natl Acad Sci U S A
89: 8818–8821.
31. Downey N, Donelson JE (1999) Search for promoters for the GARP and rRNA
genes of Trypanosoma congolense. Mol Biochem Parasitol 104: 25–38.
32. Janz L, Clayton C (1994) The PARP and rRNA promoters of Trypanosoma brucei
are composed of dissimilar sequence elements that are functionally interchange-
able. Mol Cell Biol 14: 5804–5811.
33. Lorenzi HA, Vazquez MP, Levin MJ (2003) Integration of expression vectors
into the ribosomal locus of Trypanosoma cruzi. Gene 310: 91–99.
34. Burkard G, Fragoso CM, Roditi I (2007) Highly efficient stable transformation
of bloodstream forms of Trypanosoma brucei. Mol Biochem Parasitol 153: 220–223.
35. Coustou V, Guegan F, Plazolles N, Baltz T (2010) Complete in vitro life cycle of
Trypanosoma congolense: development of genetic tools. PLoS Negl Trop Dis 4:
e618.
36. Downey N, Donelson JE (1999) Expression of foreign proteins in Trypanosoma
congolense. Mol Biochem Parasitol 104: 39–53.
37. Mahan SM, Black SJ (1989) Differentiation, multiplication and control of
bloodstream form Trypanosoma (Duttonella) vivax in mice. J Protozool 36: 424–428.
38. Mahan SM, Hendershot L, Black SJ (1986) Control of trypanodestructive
antibody responses and parasitemia in mice infected with Trypanosoma (Duttonella)
vivax. Infect Immun 54: 213–221.
39. Gardiner PR, Nene V, Barry MM, Thatthi R, Burleigh B, et al. (1996)
Characterization of a small variable surface glycoprotein from Trypanosoma vivax.
Mol Biochem Parasitol 82: 1–11.
40. Da Silva AS, Garcia Perez HA, Costa MM, Franca RT, De Gasperi D, et al.
(2010) Horses naturally infected by Trypanosoma vivax in southern Brazil. Parasitol
Res 108: 23–30.
Trypanosoma vivax Culture and Genetic Engineering
www.plosntds.org 11 December 2011 | Volume 5 | Issue 12 | e1461
41. Cortez AP, Ventura RM, Rodrigues AC, Batista JS, Paiva F, et al. (2006) The
taxonomic and phylogenetic relationships of Trypanosoma vivax from South
America and Africa. Parasitology 133: 159–169.
42. Eid J, Sollner-Webb B (1987) Efficient introduction of plasmid DNA into
Trypanosoma brucei and transcription of a transfected chimeric gene. Proc Natl
Acad Sci U S A 84: 7812–7816.
43. Kapler GM, Coburn CM, Beverley SM (1990) Stable transfection of the human
parasite Leishmania major delineates a 30-kilobase region sufficient for extrachro-
mosomal replication and expression. Mol Cell Biol 10: 1084–1094.
44. Clayton CE, Fueri JP, Itzhaki JE, Bellofatto V, Sherman DR, et al. (1990)
Transcription of the procyclic acidic repetitive protein genes of Trypanosoma
brucei. Mol Cell Biol 10: 3036–3047.
45. Cross GA, Bellofatto V, Clayton CE, Sherman DR (1990) Using transfection to
study gene expression in trypanosomes. Biochem Soc Trans 18: 714–716.
46. Kelly JM, Ward HM, Miles MA, Kendall G (1992) A shuttle vector which
facilitates the expression of transfected genes in Trypanosoma cruzi and Leishmania.
Nucleic Acids Res 20: 3963–3969.
47. Vazquez MP, Levin MJ (1999) Functional analysis of the intergenic regions of
TcP2beta gene loci allowed the construction of an improved Trypanosoma cruzi
expression vector. Gene 239: 217–225.
48. Patnaik PK, Fang X, Cross GA (1994) The region encompassing the procyclic
acidic repetitive protein (PARP) gene promoter plays a role in plasmid DNA
replication in Trypanosoma brucei. Nucleic Acids Res 22: 4111–4118.
49. Eid J, Sollner-Webb B (1991) Stable integrative transformation of Trypanosoma
brucei that occurs exclusively by homologous recombination. Proc Natl Acad
Sci U S A 88: 2118–2121.
Trypanosoma vivax Culture and Genetic Engineering
www.plosntds.org 12 December 2011 | Volume 5 | Issue 12 | e1461
